|1.||Ikeda, Hiroshi: 2 articles (06/2012 - 01/2012)|
|2.||Ichida, Wakako: 2 articles (06/2012 - 01/2012)|
|3.||Kinuya, Seigo: 2 articles (05/2009 - 06/2007)|
|4.||Ashayeri, Ebrahim: 2 articles (01/2008 - 08/2002)|
|5.||Sridhar, Rajagopalan: 2 articles (01/2008 - 08/2002)|
|6.||Jung, Hoi-In: 1 article (01/2015)|
|7.||Kim, Baek-Il: 1 article (01/2015)|
|8.||Cho, Young-Sik: 1 article (01/2015)|
|9.||Fastovets, S V: 1 article (01/2015)|
|10.||Panshin, G A: 1 article (01/2015)|
05/01/2000 - "Strontium-89 chloride (89Sr) is a new radiopharmaceutical that provides effective pain relief for metastatic bone lesions, and is expected to be available soon in the palliative management for metastatic bone pain in Japan. "
06/01/2012 - "We used combination therapy of strontium-89 chloride for the treatment of widespread multiple bone pain and external-beam radiation therapy for localized pain. "
09/01/1991 - "Strontium-89 chloride for pain palliation in prostatic skeletal malignancy."
08/01/2014 - "Sr-89 chloride (Metastron) was given by single intravenous infusion at 2 MBq/kg over 2 min. Self-reported outcome measures were used as a response index, including pain diary data on a 0-10 numeric rating scale (NRS). "
10/01/1997 - "We have used strontium-89 chloride (89Sr) for the palliative treatment of metastatic bone pain. "
|2.||Prostatic Neoplasms (Prostate Cancer)
07/01/1994 - "The objectives of the study were to estimate the cost of medical care for patients recruited into the Trans Canada trial of Metastron (89Sr-chloride) as adjunct therapy in patients with prostate cancer metastatic to bone and to compare the costs of those receiving Metastron with those receiving placebo. "
01/01/1994 - "Various studies have been conducted to evaluate the role of Metastron in metastatic prostate cancer. "
01/01/1997 - "[The role of metastron in the treatment of prostate cancer]."
07/01/1994 - "This retrospective study suggests that treatment with Metastron can bring about meaningful reductions in lifetime management costs in patients with advanced prostate cancer. "
07/01/1994 - "A retrospective analysis of the cost effectiveness of treatment with Metastron (89Sr-chloride) in patients with prostate cancer metastatic to bone."
|3.||Neoplasm Metastasis (Metastasis)
06/01/2007 - "The aim of this study was to evaluate changes in the peripheral blood CD(4)(+) and CD(8)(+) T-lymphocyte populations following strontium-89 chloride ((89)SrCl(2)) therapy for painful bone metastases and to relate these changes to a therapeutic response. "
01/01/2012 - "[Strontium chloride (89Sr-chloride) fractional injection method for bone metastases treatment]."
01/01/2012 - "These results led us to the conclusion that the indication and inclusion criteria for strontium-89 chloride treatment should be patients with an earlier bone metastasis burden that is currently manifested, without too much attention to bone marrow function criteria."
01/01/2012 - "Strontium-89 chloride has been available at our hospital for painful osseous metastases since October 2008. "
01/01/2012 - "[Initial report of strontium-89 chloride treatment for painful osseous metastases at Sakai Municipal Hospital]."
01/01/1994 - "Patients (n = 29) recruited into the trans Canada trial at the Cross Cancer Institute, Edmonton and randomized to treatment with Metastron (strontium-89 chloride) (n = 14) or placebo (n = 15) after local field irradiation therapy for pain palliation were studied over their entire survival time. "
12/01/1996 - "The phase III clinical trial of strontium-89 chloride agent (SMS.2P) was performed in 90 patients with painful bone metastases secondary to prostate (53), breast (18) and other types of cancer (19). "
08/01/1995 - "Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron)."
03/01/1913 - "5. Simultaneous injection of M/6 strontium chloride solution into the tumors does not appreciably affect the action of the lecithin."
07/20/2010 - "The radiopharmaceutical strontium chloride ((89)Sr) has been released as a new means of pain relief for painful bone metastasis in cancer patients. "
07/01/1987 - "Efficacy of strontium chloride in dental hypersensitivity."
05/01/1991 - "The purpose of this study was to assess the effect of topical application of a sustained-release device in form of a varnish containing strontium chloride on dentinal hypersensitivity. "
01/01/1987 - "[Strontium chloride in the treatment of dental hypersensitivity]."
07/01/1985 - "Clinical evaluation of strontium chloride as a modified addition to the periodontal pack, in treatment of root hypersensitivity following periodontal surgery."
07/01/1987 - "The results from all three methods of assessment indicated that the strontium chloride dentifrice, in comparison with a placebo, reduced dentinal hypersensitivity to a significantly greater degree. "
|2.||strontium chloride (strontium chloride Sr 89)
|4.||potassium nitrate (saltpeter)
|7.||Silicon Dioxide (Sand)
|9.||Diatomaceous Earth (Kieselguhr)
|2.||Palliative Care (Palliative Medicine)
|5.||Drug Therapy (Chemotherapy)